Gelesis, in collaboration with MCPHS, offers a unique fellowship to promote the role of the Doctor of Pharmacy (PharmD) within the biopharmaceutical industry. Fellows gain extensive experience through various practical activities in both industry and academic settings, which will enhance the potential for accelerated career development.
Gelesis is not currently recruiting a fellow for the 2022-2024 academic year.
Founded in 2006, Gelesis is a biotechnology company developing a novel hydrogel technology platform for GI-related chronic diseases. The proprietary Gelesis platform is the first and only superabsorbent hydrogel made exclusively from naturally derived building blocks. In April 2019, Gelesis received FDA clearance for its lead product candidate, Plenity™, as an aid to weight management in adults with excess weight or obesity, with a Body Mass Index (BMI) of 25-40 kg/m2, when used in conjunction with diet and exercise. Novel hydrogel mechanotherapeutics based on the Gelesis platform technology are also being advanced in type 2 diabetes, and other GI inflammatory conditions, such as non-alcoholic steatohepatitis (NASH) and chronic idiopathic constipation (CIC).
The Gelesis executive and advisory team includes some of the world’s leading experts in obesity, materials science, chronic disease research, and commercialization. Gelesis was co-founded by PureTech Health, a clinical stage biotherapeutics company dedicated to discovering, developing, and commercializing highly differentiated medicines for devastating diseases.
At Gelesis, we believe we can empower people to change their diet, lifestyle, and health. Named by Fast Company as one of the most innovative biotechnology companies of 2020, our mission is to bring a new approach to the millions of people looking for a safe, validated, and convenient approach to manage their weight.
Medical Affairs Fellowship
The Gelesis two-year Post-PharmD Industry Fellowship is intended to provide a comprehensive experience for Doctor of Pharmacy graduates within the functional area of Medical Affairs.
The post-doctoral fellow will be a core contributing member of the Medical Affairs team. During the fellowship, he or she will develop functional expertise by supporting multiple cross-functional teams and assume increasing responsibility for independent projects as the fellowship proceeds.
The responsibilities of the post-doctoral fellow include but are not limited to creation of and updating global standard response letters (SRL), slide presentations, responding to medical inquiries from healthcare professionals by conducting literature analyses and developing customized medical responses, and providing medical information support at scientific meetings. The post-doctoral fellow will develop expertise and contribute to various medical affairs projects, including analyses of clinical data, poster/publication development, and medical affairs strategic planning for launch products. The post-doctoral medical affairs fellow will have the opportunity to engage with obesity management key opinion leaders and some of the world’s leading experts in obesity. The post-doctoral fellow will play an important role on the Medical Affairs team and immerse themselves in the heart of a small biotechnology company.